Valuation: Kenvue Inc.

Market Cap 36.88B 31.97B 29.97B 27.32B 51.41B 3,520B 52.24B 353B 138B 1,762B 138B 135B 5,877B P/E 2026 *
20.2x
P/E 2027 * 17.8x
Enterprise Value 43.94B 38.09B 35.71B 32.56B 61.26B 4,194B 62.24B 420B 164B 2,099B 165B 161B 7,003B EV / Sales 2026 *
2.82x
EV / Sales 2027 * 2.72x
Free-Float
98.88%
Yield 2026 *
4.41%
Yield 2027 * 4.49%
1 day+1.16%
1 week+0.10%
Current month-0.21%
1 month-0.16%
3 months+11.69%
6 months+2.67%
Current year+11.30%
1 week 18.65
Extreme 18.65
19.28
1 month 18.58
Extreme 18.58
20.05
Current year 16.56
Extreme 16.555
20.13
1 year 14.02
Extreme 14.02
21.84
3 years 14.02
Extreme 14.02
25.17
5 years 14.02
Extreme 14.02
27.8
10 years 14.02
Extreme 14.02
27.8
Manager TitleAgeSince
Chief Executive Officer 56 2025-07-13
Director of Finance/CFO 48 2026-05-11
Chief Tech/Sci/R&D Officer 57 -
Director TitleAgeSince
Chairman 70 2023-04-30
Director/Board Member 66 2023-05-03
Director/Board Member 59 2023-05-07
Date Insider Type Main position Quantity % Market Cap.
7/31/26 Fiscal year

Executive/Senior Manager

32,838 0.0017%
5/1/26 Fiscal year

Group President LATAM

55,637 0.0029%
3/30/26 Free

Director

1,331 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
+1.16%+0.10%-11.56%-19.06% 36.88B
+0.12%-1.84%-7.17%-8.13% 335B
-0.52%-1.34%-9.29%-0.01% 135B
+0.66%-0.08%+7.63%+20.85% 74.08B
-0.72%-0.91%-16.27%-18.01% 51.5B
-0.41%+2.14%-8.34%-47.91% 31.59B
-0.67%-3.31%+5.89%+21.72% 20.19B
+0.25%-3.05%-22.14%-35.10% 19.77B
-0.20%-1.88%+12.24%+5.53% 19.65B
-0.28%-11.02%-21.15%-9.78% 10.04B
Average -0.06%-2.06%-7.02%-8.99% 73.36B
Weighted average by Cap. +0.04%-1.39%-6.69%-6.23%

Financials

2026 *2027 *
Net sales 15.6B 13.52B 12.67B 11.55B 21.74B 1,488B 22.09B 149B 58.25B 745B 58.55B 57.28B 2,485B 15.97B 13.84B 12.97B 11.83B 22.26B 1,524B 22.62B 153B 59.64B 763B 59.95B 58.65B 2,545B
Net income 1.83B 1.59B 1.49B 1.36B 2.55B 175B 2.59B 17.53B 6.84B 87.52B 6.88B 6.73B 292B 2.09B 1.81B 1.69B 1.54B 2.91B 199B 2.95B 19.95B 7.79B 99.62B 7.83B 7.66B 332B
Net Debt 7.07B 6.12B 5.74B 5.23B 9.85B 674B 10.01B 67.6B 26.39B 338B 26.52B 25.95B 1,126B 6.59B 5.71B 5.35B 4.88B 9.19B 629B 9.33B 63.05B 24.61B 315B 24.74B 24.2B 1,050B
Logo Kenvue Inc.
Kenvue Inc. is one of the world leaders in the design, manufacture and marketing of consumer healthcare products. The group offers products for health, beauty, baby care, oral care, skin care and more. Net sales break down by family of products as follows: - self care products (42,3%): for the treatment of coughs, colds, allergies, pain, indigestion, constipation, etc. (brands Zyrtec, Benadryl, Zarbee's, Frenadol, Codral, Reactine, Tylenol, Motrin, Calpol, Nicorette, Imodium, Pepcid, Microlax, Daktarin, etc.); - personal care products (30.3%): primarily oral care, baby care, women's health and wound care products (Listerine, Desitin, Carefree, Stayfree, Band-Aid, Neosporin brands, etc.); - beauty and skin care products (27.4%): hair care products, sun protection products, face and body care products, etc. (Neutrogena, Aveeno, Clean&Clear, Lubriderm, Johnsons, Neostrata, OGX, Rogaine brands, etc.). Product marketing is assured through direct sales, distributors and the Internet. Net sales are distributed geographically as follows: North America (49%), Europe-Middle East-Africa (23%), Asia-Pacific (19.3%) and Latin America (8.7%).
Employees
21,890
Date Price Change Volume
26-08-13 US$19.20 +1.16% 17,042,522
26-08-12 US$18.98 -0.37% 11,026,140
26-08-11 US$19.05 +0.11% 12,782,165
26-08-10 US$19.03 -1.04% 25,550,069
26-08-07 US$19.23 +0.26% 14,325,931
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
19.20USD
Average target price
19.50USD
Spread / Average Target
+1.56%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. KVUE Stock